Long Term Open Follow-up With H376/95 vs. Warfarin

NCT00206063 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2010-11-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate tolerability of long-term treatment with ximelagatran compared to standard treatment with warfarin.

Conditions

  • Stroke Prevention in Patients With Atrial Fibrillation

Interventions

DRUG

EXANTA

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-08-31
Primary Completion
2004-06-30
Completion
2006-04-30

Countries

  • United States
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Norway
  • Poland
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00206063 on ClinicalTrials.gov